{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T12:29:36Z","timestamp":1791289776536,"version":"4.3.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajkd.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1053\/j.ajkd.2015.03.039","type":"journal-article","created":{"date-parts":[[2015,5,23]],"date-time":"2015-05-23T08:46:05Z","timestamp":1432370765000},"page":"331-336","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Distal Angiopathy and Atypical Hemolytic Uremic Syndrome: Clinical and Functional Properties of an Anti\u2013Factor H IgA\u03bb Antibody"],"prefix":"10.1053","volume":"66","clinical-trial-number":[{"clinical-trial-number":"nct00838513","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Claire","family":"Rigothier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yahsou","family":"Delmas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lubka T.","family":"Roumenina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile","family":"Contin-Bordes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9bastien","family":"Lepreux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Bridoux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Michel","family":"Goujon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Bachelet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy","family":"Touchard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Fr\u00e9meaux-Bacchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Combe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"18","key":"10.1053\/j.ajkd.2015.03.039_bib1","doi-asserted-by":"crossref","first-page":"4182","DOI":"10.1182\/blood-2011-10-383281","article-title":"A\u00a0prevalent C3 mutation in aHUS patients causes a direct C3 convertase gain of function","volume":"119","author":"Roumenina","year":"2012","journal-title":"Blood"},{"issue":"13","key":"10.1053\/j.ajkd.2015.03.039_bib2","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1182\/blood-2009-01-197640","article-title":"Hyperfunctional C3 convertase leads to complement deposition on endothelial cells and contributes to atypical hemolytic uremic syndrome","volume":"114","author":"Roumenina","year":"2009","journal-title":"Blood"},{"issue":"8","key":"10.1053\/j.ajkd.2015.03.039_bib3","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1172\/JCI16651","article-title":"Mutations in factor H reduce binding affinity to C3b and heparin and surface attachment to endothelial cells in hemolytic uremic syndrome","volume":"111","author":"Manuelian","year":"2003","journal-title":"J\u00a0Clin Invest"},{"issue":"5720","key":"10.1053\/j.ajkd.2015.03.039_bib4","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1126\/science.1109557","article-title":"Complement factor H polymorphism in age-related macular degeneration","volume":"308","author":"Klein","year":"2005","journal-title":"Science"},{"issue":"3","key":"10.1053\/j.ajkd.2015.03.039_bib5","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1182\/blood-2007-09-109876","article-title":"Factor H autoantibodies in atypical hemolytic uremic syndrome correlate with CFHR1\/CFHR3 deficiency","volume":"111","author":"Jozsi","year":"2008","journal-title":"Blood"},{"issue":"23","key":"10.1053\/j.ajkd.2015.03.039_bib6","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1056\/NEJMoa1208981","article-title":"Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome","volume":"368","author":"Legendre","year":"2013","journal-title":"N\u00a0Engl J Med"},{"issue":"7","key":"10.1053\/j.ajkd.2015.03.039_bib7","doi-asserted-by":"crossref","first-page":"3528","DOI":"10.4049\/jimmunol.1200679","article-title":"Overall neutralization of complement factor H by autoantibodies in the acute phase of the autoimmune form of atypical hemolytic uremic syndrome","volume":"189","author":"Blanc","year":"2012","journal-title":"J\u00a0Immunol"},{"issue":"6","key":"10.1053\/j.ajkd.2015.03.039_bib8","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1086\/344515","article-title":"Structural and functional characterization of factor H mutations associated with atypical hemolytic uremic syndrome","volume":"71","author":"Sanchez-Corral","year":"2002","journal-title":"Am J Hum Genet"},{"key":"10.1053\/j.ajkd.2015.03.039_bib9","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/978-1-62703-724-2_19","article-title":"Functional evaluation of factor H genetic and acquired abnormalities: application for atypical hemolytic uremic syndrome (aHUS)","volume":"1100","author":"Roumenina","year":"2014","journal-title":"Methods Mol Biol"},{"issue":"4","key":"10.1053\/j.ajkd.2015.03.039_bib10","doi-asserted-by":"crossref","first-page":"554","DOI":"10.2215\/CJN.04760512","article-title":"Genetics and outcome of atypical hemolytic uremic syndrome: a nationwide French series comparing children and adults","volume":"8","author":"Fremeaux-Bacchi","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"10.1053\/j.ajkd.2015.03.039_bib11","doi-asserted-by":"crossref","first-page":"e331","DOI":"10.1542\/peds.2012-0903","article-title":"Peripheral gangrene in children with atypical hemolytic uremic syndrome","volume":"131","author":"Malina","year":"2013","journal-title":"Pediatrics"},{"issue":"5","key":"10.1053\/j.ajkd.2015.03.039_bib12","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s00467-002-0973-4","article-title":"Peripheral gangrene complicating hemolytic uremic syndrome in a child","volume":"18","author":"Ozel","year":"2003","journal-title":"Pediatr Nephrol"},{"issue":"10-11","key":"10.1053\/j.ajkd.2015.03.039_bib13","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1007\/s004670050058","article-title":"Peripheral gangrene complicating idiopathic and recessive hemolytic uremic syndromes","volume":"14","author":"Kaplan","year":"2000","journal-title":"Pediatr Nephrol"},{"issue":"4","key":"10.1053\/j.ajkd.2015.03.039_bib14","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1053\/j.ajkd.2009.08.011","article-title":"Maintenance of kidney function following treatment with eculizumab and discontinuation of plasma exchange after a third kidney transplant for atypical hemolytic uremic syndrome associated with a CFH mutation","volume":"55","author":"Davin","year":"2010","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"10.1053\/j.ajkd.2015.03.039_bib15","doi-asserted-by":"crossref","first-page":"e34","DOI":"10.3174\/ajnr.A0965","article-title":"Proximal cerebral artery stenosis in a patient with hemolytic uremic syndrome","volume":"29","author":"Vergouwen","year":"2008","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1053\/j.ajkd.2015.03.039_bib16","doi-asserted-by":"crossref","first-page":"3421","DOI":"10.1093\/ndt\/gfq319","article-title":"Non-atheromatous arterial stenoses in atypical haemolytic uraemic syndrome associated with complement dysregulation","volume":"25","author":"Loirat","year":"2010","journal-title":"Nephrol Dial Transplant"},{"issue":"12","key":"10.1053\/j.ajkd.2015.03.039_bib17","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1681\/ASN.2010030315","article-title":"Clinical features of anti-factor H autoantibody-associated hemolytic uremic syndrome","volume":"21","author":"Dragon-Durey","year":"2010","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2015.03.039_bib18","doi-asserted-by":"crossref","unstructured":"Herrmann SM, Govani MV, Fidler ME, et al. Recurrence of monoclonal IgA lambda glomerulonephritis in kidney allograft associated with multiple myeloma [published online ahead of print November 5, 2014]. Clin Nephrol. http:\/\/dx.doi.org\/10.5414\/CN108339.","DOI":"10.5414\/CN108339"},{"key":"10.1053\/j.ajkd.2015.03.039_bib19","doi-asserted-by":"crossref","unstructured":"Sinha A, Gulati A, Saini S, et al. Prompt plasma exchanges and immunosuppressive treatment improves the outcomes of antifactor H autoantibody-associated hemolytic uremic syndrome in children [published online ahead of print October 2, 2013]. Kidney Int. http:\/\/dx.doi.org\/10.1038\/ki.2013.373.","DOI":"10.1038\/ki.2013.373"},{"issue":"4","key":"10.1053\/j.ajkd.2015.03.039_bib20","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/ki.2011.152","article-title":"Factor H-related protein 1 neutralizes anti-factor H autoantibodies in autoimmune hemolytic uremic syndrome","volume":"80","author":"Strobel","year":"2011","journal-title":"Kidney Int"},{"issue":"8","key":"10.1053\/j.ajkd.2015.03.039_bib21","doi-asserted-by":"crossref","first-page":"4590","DOI":"10.4049\/jimmunol.163.8.4590","article-title":"Nephritogenic lambda light chain dimer: a unique human miniautoantibody against complement factor H","volume":"163","author":"Jokiranta","year":"1999","journal-title":"J\u00a0Immunol"},{"key":"10.1053\/j.ajkd.2015.03.039_bib22","doi-asserted-by":"crossref","unstructured":"Cheungpasitporn W, Leung N, Sethi S, Gertz MA,Fervenza\u00a0FC. Refractory atypical hemolytic uremic syndrome with monoclonal gammopathy responsive to bortezomib-based therapy [published online ahead of print October 27, 2014]. Clin Nephrol. http:\/\/dx.doi.org\/10.5414\/CN108363.","DOI":"10.5414\/CN108363"},{"issue":"11","key":"10.1053\/j.ajkd.2015.03.039_bib23","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/nrneph.2012.214","article-title":"Use of eculizumab for atypical haemolytic uraemic syndrome and C3 glomerulopathies","volume":"8","author":"Zuber","year":"2012","journal-title":"Nat Rev Nephrol"}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638615007064?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638615007064?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T02:39:40Z","timestamp":1759459180000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272638615007064"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["S0272638615007064"],"URL":"https:\/\/doi.org\/10.1053\/j.ajkd.2015.03.039","relation":{},"ISSN":["0272-6386"],"issn-type":[{"value":"0272-6386","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Distal Angiopathy and Atypical Hemolytic Uremic Syndrome: Clinical and Functional Properties of an Anti\u2013Factor H IgA\u03bb Antibody","name":"articletitle","label":"Article Title"},{"value":"American Journal of Kidney Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2015.03.039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}